S'abonner

Financial heist from counterfeit drug: A case study from Delhi, India - 15/08/22

Doi : 10.1016/j.toxac.2022.06.186 
Kavita Goyal, Dr.
 Chemistry, Forensic science laboratory, Delhi, New Delhi, India 

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Background

Drug abuse has become a severe social-economic problem, which is vulnerably affecting different age groups. All the regulatory bodies involved in strategic reduction in drug abuse need to strengthen to ensure effective implementation for combating illicit drug abuse. Also, many a times people are duped by spurious drugs, which have a stupefying effect on the victim and cheat them of their valuable belongings. The victim reports such cases after the incident to the concerned investigating agencies who subsequently register and strategize to nab the culprit. The seized materials from the culprit/accused persons are subsequently sent for forensic examination. The Forensic Science Laboratory receives many such cases of drug poisoning/overdose, spurious/illicit drugs.

A case of a 40-year-old victim/farmer, who was robbed of his belongings at a bus depot, was registered in Forensic Science Laboratory, Delhi. A brief history of the case was that he was waiting to board a bus for a further journey; whereby he met the accused persons who befriended him and together they had some food. Later as there was further delay in the bus, they went to a restaurant at the bus depot, had tea and biscuits and slept. Later, the victim was discovered unconscious by investigating agencies who took him to the hospital. The Medico-Legal Certificate report indicated him to be drowsy and unfit for statement at the time of admission and therefore preserved his blood sample for chemical analysis. The victim later said that the accused had stolen his belongings, especially money. Investigating agencies corroborated small pieces of evidence finally to nab the accused and seized a medicine strip claiming it to be the sedative drug ‘Nitrazepam’ which was administered to the victim. The blood sample of the victim and the strip of tablets seized from the accused were submitted for forensic examination.

Methodology

The samples received in the present case were white coloured tablets and blood sample. On visual examination, the tablets appeared similar to that of manufactured pharmaceutical drug ‘Nitrazepam’. Preliminary examination gave surprising results. Therefore, detailed chemical and instrumental analysis using the techniques gas chromatography mass spectroscopy (GC-MS), high performance thin layer chromatography (HPTLC), Fourier transform infrared spectroscopy (FTIR), and ultra performance liquid chromatography (UPLC) were carried out to ascertain the contents in the tablets, that have stupefying effect.

Results and discussion

Preliminary screening by thin layer chromatography (TLC) did not indicate the presence of ‘Nitrazepam’ [the separated components did not tally with the certified reference material (CRM) of ‘Nitrazepam’]. GC-MS examination of the sample indicated the probable presence of pheniramine (78%) and chlorpheniramine (83%) using the National Institute of Standard and Technology (NIST) database. Detailed analysis using the techniques HPTLC, FTIR and UPLC was carried out to ascertain the exact components in the tablets and blood sample. They were found to contain ‘Chlorpheniramine’ rather than ‘Nitrazepam’ as imprinted by the manufacturer. It is important to mention here that even Chlorpheniramine has sedative effect, apart from acting as an antihistamine medicine.

Conclusion

An interesting case of robbing was deduced; with a simultaneous disclosure of counterfeit drugs, which may be blooming in the market. With the development of modern analytical techniques, even trace samples can be examined and have special significance while dealing with crime and criminals.

Le texte complet de cet article est disponible en PDF.

Plan


© 2022  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 34 - N° 3S

P. S116-S117 - septembre 2022 Retour au numéro
Article précédent Article précédent
  • In vitro approaches for the identification and characterization of urinary metabolite biomarkers of synthetic cannabinoid ADB-BUTINACA
  • Evelyn Mei Ling Goh, Chi Hon Sia, Ziteng Wang, Ching Yee Fong, Hooi Yan Moy, Eric Chun Yong Chan
| Article suivant Article suivant
  • Cancelled by the authors

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.